Skip to main content
Clinical Trials/NCT00692133
NCT00692133
Completed
N/A

Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment

AstraZeneca1 site in 1 country250 target enrollmentMarch 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
AstraZeneca
Enrollment
250
Locations
1
Primary Endpoint
TOOL questionnaire
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

Non-interventional, prospective study to validate Spanish version of TOOL questionnaire in patients with schizophrenia and bipolar disorder under antipsychotic treatment

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
August 2008
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Schizophrenia and bipolar disorder (DSM-IV criteria)
  • Stabilized out-patients
  • Treated with the same oral antipsychotic at least in the last month

Exclusion Criteria

  • Participation in another clinical trial within 6 months prior to enrolment into this study
  • Administration of a depot antipsychotic medication

Outcomes

Primary Outcomes

TOOL questionnaire

Time Frame: 15 days

PANSS & Young Mania Scale

Time Frame: 15 days

Secondary Outcomes

  • Montgomery Asberg Depression Scale(15 days)
  • Euroqol 5D & SF-36D(performed only at baseline visit)
  • UKU modified scale(performed only at baseline visit)

Study Sites (1)

Loading locations...

Similar Trials